CARMEL, Ind., Feb. 18, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ...
Further signs that the biotech initial public offering (IPO) market is picking up have come with a filing by MBX Biosciences, seeking around $100 million to take a hypoparathyroidism candidate ...
Pre-market: 5:59:46 am GMT-5 ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Competitors like AstraZeneca (NASDAQ:AZN) and MBX Biosciences are working on treatments that could potentially challenge Ascendis Pharma's market position. In the achondroplasia space, Biomarin's ...
At close: February 18 at 3:59:59 p.m. EST ...
After hours: February 20 at 4:20:00 PM EST Loading Chart for BCAX ...
3 MORE 2002 Embraer ERJ-145XR Aircraft Available!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback